Evidence map›Paper›PMID 21892188›Full record

ArticleNature2011

The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase.

Dea Slade, Mark S Dunstan, Eva Barkauskaite, Ria Weston, Pierre Lafite, Neil Dixon, Marijan Ahel, David Leys, Ivan Ahel

Open access · greenAbstract read
In one paragraph

Article in Nature, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 251 papers.

0numbers the graph read from it
0cells of the map it votes in
251citing papers in PubMed
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

251 citing papers in PubMed, 372 citations in OpenAlex.

  1. Article
  2. Article
  3. RSF1-Dependent PAR Turnover Promotes 53BP1 Liquid Condensate Formation at DNA Damage Sites.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Disordered Protein Tail Is Wagging Poly(ADP-ribosyl)ation.International journal of molecular sciences · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

191 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Dea SladeCancer Research UK, Paterson Institute for Cancer Research, University of Manchester, Wilmslow Road, Manchester M20 4BX, UK.
Mark S Dunstan
Eva Barkauskaite
Ria Weston
Pierre Lafite
Neil Dixon
Marijan Ahel
David Leys
Ivan Ahel
University of Manchester · GBCancer Research UK Manchester Institute · GBCentre National de la Recherche Scientifique · FRRudjer Boskovic Institute · HR

Funding

Cancer Research UK A6058
6 · The paper itself

Abstract

Post-translational modification of proteins by poly(ADP-ribosyl)ation regulates many cellular pathways that are critical for genome stability, including DNA repair, chromatin structure, mitosis and apoptosis. Poly(ADP-ribose) (PAR) is composed of repeating ADP-ribose units linked via a unique glycosidic ribose-ribose bond, and is synthesized from NAD by PAR polymerases. PAR glycohydrolase (PARG) is the only protein capable of specific hydrolysis of the ribose-ribose bonds present in PAR chains; its deficiency leads to cell death. Here we show that filamentous fungi and a number of bacteria possess a divergent form of PARG that has all the main characteristics of the human PARG enzyme. We present the first PARG crystal structure (derived from the bacterium Thermomonospora curvata), which reveals that the PARG catalytic domain is a distant member of the ubiquitous ADP-ribose-binding macrodomain family. High-resolution structures of T. curvata PARG in complexes with ADP-ribose and the PARG inhibitor ADP-HPD, complemented by biochemical studies, allow us to propose a model for PAR binding and catalysis by PARG. The insights into the PARG structure and catalytic mechanism should greatly improve our understanding of how PARG activity controls reversible protein poly(ADP-ribosyl)ation and potentially of how the defects in this regulation are linked to human disease.

Indexed as

ActinomycetalesAdenosine DiphosphateAdenosine Diphosphate RiboseAmino Acid SequenceBiocatalysisCatalytic DomainCrystallography, X-RayEvolution, MolecularGlycoside HydrolasesHumansHydrolysisModels, MolecularMolecular Sequence DataPhylogenyPoly Adenosine Diphosphate RibosePoly (ADP-Ribose) Polymerase-1Adenosine Diphosphateadenosine diphosphate (hydroxymethyl)pyrrolidinediolAdenosine Diphosphate RiboseGlycoside HydrolasesPARP1 protein, humanPoly Adenosine Diphosphate Ribosepoly ADP-ribose glycohydrolasePoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) Polymerasespoly(ADP)-ribosylated proteinsProteinsPyrrolidines

Identifiers

PMID21892188
PMCPMC3184140
OpenAlexW2158389792

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.